HemoSonics

HemoSonics is a medical device company based in Charlottesville, Virginia, focused on advanced diagnostic technology for managing coagulation dysfunctions, particularly in acute care settings. Founded by experts in the field, the company aims to enhance clinical decision-making by delivering timely and actionable information about a patient's coagulation status, ultimately improving patient outcomes and reducing healthcare costs. The flagship product, the Quantra® Hemostasis Analyzer, utilizes proprietary SEER Sonorheometry technology to provide comprehensive coagulation analysis in under 15 minutes. This system is designed for use in critical care environments, such as operating rooms and intensive care units, where rapid assessment is essential. HemoSonics serves acute care professionals and healthcare institutions, helping them manage major bleeding and thrombosis effectively. The company is recognized for its strong market presence and growth, driven by the adoption of its innovative diagnostic tools.

• Employees120
• Founded2004
• Annual Revenue$50000000
• Total Funding$23920332